KEY POINTS
  • As regulatory risks rise in China, investors should reduce their exposure to Chinese stocks listed in the U.S., according to Jack Siu, chief investment officer for Greater China at Credit Suisse.
  • "We think it's prudent for holders of these stocks to ... diversify, hedge their exposure, maybe switching to some of the Hong Kong-listed stocks where there's a dual listing to hedge against this delisting risk," Siu said.
  • Many companies targeted by Chinese regulators have ADR listings in the U.S., while the Securities and Exchange Commission finalized rules that allow it to delist foreign stocks if they don't meet audit requirements.

In this article

As regulatory risks rise in China, investors should reduce their exposure to Chinese stocks listed in the U.S., according to Jack Siu, chief investment officer for Greater China at Credit Suisse.

"The uncertainties to ... regulatory related events are presenting risks to investors in the next 12 to 18 months," Siu told CNBC's "Street Signs Asia" on Thursday.

In this article